Pepdox
Studies
Peptides
Calculator
Home
/
Search
/
PMID 38224977
Semaglutide reduces the absolute risk of major cardiovascular events by 1.5.
BMJ (Clinical research ed.)
2024
PMID: 38224977
View on PubMed
DOI: 10.1136/bmj.q53
Semaglutide
Authors
Phizackerley, David
Semaglutide reduces the absolute risk of major cardiovascular events by 1.5. | Pepdox